We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Biovail to Acquire Rights to Develop, Commercialize JP-1730/Fipamezole in North America from Santhera

News   Aug 31, 2009

 
Biovail to Acquire Rights to Develop, Commercialize JP-1730/Fipamezole in North America from Santhera
 
 
 

RELATED ARTICLES

Drug Targets Early Instigator of Alzheimer's Disease

News

Therapeutic efforts to target "plaques and tangles", considered classic hallmarks of Alzheimer's disease, have previously met with dispiriting failure. Now researchers are exploring a drug called "DYR219" – its strength lies in the fact that it can target both plaques and tangles.

READ MORE

Drug Could Speed Up Blood System’s Recovery After Chemo, Suggests Mouse Study

News

A drug has been developed that speeds up the regeneration of mouse and human blood stem cells after exposure to radiation. If these results can be replicated in humans, the compound known as "DJ009" could help people recover quicker from chemotherapy, radiation and bone marrow transplants.

READ MORE

Microbial Hitchhikers Churn Out Heaps of Tiny Novel Proteins

News

The bacteria in our gut make thousands of tiny, previously unidentified proteins that could shed light on human health and advance drug development, Stanford researchers have discovered.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE